Antimicrobial resistance landscape in Africa: Perspectives from the World Health Organization GLASS report 2025.

Emnet Tesfaye Shimber, Mikiyas G Teferi, Kebron W Aweke, Biruktawit Zemede Lemma, Getaw W Hassen

Abstract readReview

In one paragraph

Review in IJID regions, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it

0cells of the map it votes in

0citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Emnet Tesfaye ShimberDepartment of Emergency Medicine, African Health Sciences University, Kigali, Rwanda.

Mikiyas G TeferiSchool of Medicine, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia.

Kebron W AwekeSchool of Medicine, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia.

Biruktawit Zemede LemmaDepartment of Emergency Medicine, African Health Sciences University, Kigali, Rwanda.

Getaw W HassenSchool of Medicine, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Antimicrobial resistance (AMR) represents a growing public health threat in Africa, where surveillance capacity and antimicrobial stewardship remain limited. Using findings from the World Health Organization (WHO) Global Antimicrobial Resistance and Use Surveillance System (GLASS) Report 2025, this commentary highlights the disproportionate burden of resistant infections across the continent, major gaps in laboratory infrastructure, and incomplete national surveillance coverage. Weak diagnostic capacity, widespread empirical antibiotic use, and misalignment with WHO Access, Watch, and Reserve (AWaRe) targets further exacerbate resistance. Strengthening AMR surveillance, diagnostics, and antimicrobial stewardship, and governance across all levels of the healthcare system is essential to mitigate AMR and advance Universal Health Coverage in low-resource settings.

Indexed as

AfricaAntimicrobial resistanceAntimicrobial stewardshipSurveillance systemsWHO GLASS

Identifiers

PMID41909461

DOI10.1016/j.ijregi.2026.100866

PMCPMC13018951

What OpenQuestion holds

Textmetadata

LicenceCC BY

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.